346 related articles for article (PubMed ID: 10936216)
21. Synaptic remodeling at the skeletal neuromuscular junction of acetylcholinesterase knockout mice and its physiological relevance.
Girard E; Barbier J; Chatonnet A; Krejci E; Molgó J
Chem Biol Interact; 2005 Dec; 157-158():87-96. PubMed ID: 16274683
[TBL] [Abstract][Full Text] [Related]
22. Potent AChE and BChE inhibitors isolated from seeds of Peganum harmala Linn by a bioassay-guided fractionation.
Yang Y; Cheng X; Liu W; Chou G; Wang Z; Wang C
J Ethnopharmacol; 2015 Jun; 168():279-86. PubMed ID: 25862961
[TBL] [Abstract][Full Text] [Related]
23. Interaction of exogenous acetylcholinesterase and butyrylcholinesterase with amyloid-β plaques in human brain tissue.
Reid GA; Darvesh S
Chem Biol Interact; 2024 May; 395():111012. PubMed ID: 38648920
[TBL] [Abstract][Full Text] [Related]
24. Evidence for nonacetylcholinesterase targets of organophosphorus nerve agent: supersensitivity of acetylcholinesterase knockout mouse to VX lethality.
Duysen EG; Li B; Xie W; Schopfer LM; Anderson RS; Broomfield CA; Lockridge O
J Pharmacol Exp Ther; 2001 Nov; 299(2):528-35. PubMed ID: 11602663
[TBL] [Abstract][Full Text] [Related]
25. Inhibition kinetics of acetylcholinesterase and butyrylcholinesterase from various species by 2-(2-cresyl)-4H-1,3,2-benzodioxaphosphorin-2-oxide (CBDP).
Horn G; Rappenglück S; Worek F
Toxicol Lett; 2024 May; 396():28-33. PubMed ID: 38642675
[TBL] [Abstract][Full Text] [Related]
26. Reduced acetylcholine receptor density, morphological remodeling, and butyrylcholinesterase activity can sustain muscle function in acetylcholinesterase knockout mice.
Adler M; Manley HA; Purcell AL; Deshpande SS; Hamilton TA; Kan RK; Oyler G; Lockridge O; Duysen EG; Sheridan RE
Muscle Nerve; 2004 Sep; 30(3):317-27. PubMed ID: 15318343
[TBL] [Abstract][Full Text] [Related]
27. Acetylcholinesterase and butyrylcholinesterase activities in obese Beagle dogs before and after weight loss.
Tvarijonaviciute A; Ceron JJ; Tecles F
Vet Clin Pathol; 2013 Jun; 42(2):207-11. PubMed ID: 23550593
[TBL] [Abstract][Full Text] [Related]
28. Cholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase.
Pacheco G; Palacios-Esquivel R; Moss DE
J Pharmacol Exp Ther; 1995 Aug; 274(2):767-70. PubMed ID: 7636741
[TBL] [Abstract][Full Text] [Related]
29. Naturally Occurring Genetic Variants of Human Acetylcholinesterase and Butyrylcholinesterase and Their Potential Impact on the Risk of Toxicity from Cholinesterase Inhibitors.
Lockridge O; Norgren RB; Johnson RC; Blake TA
Chem Res Toxicol; 2016 Sep; 29(9):1381-92. PubMed ID: 27551784
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, molecular docking and biological evaluation of N,N-disubstituted 2-aminothiazolines as a new class of butyrylcholinesterase and carboxylesterase inhibitors.
Makhaeva GF; Boltneva NP; Lushchekina SV; Serebryakova OG; Stupina TS; Terentiev AA; Serkov IV; Proshin AN; Bachurin SO; Richardson RJ
Bioorg Med Chem; 2016 Mar; 24(5):1050-62. PubMed ID: 26827140
[TBL] [Abstract][Full Text] [Related]
31. Brain region-specific effects of immobilization stress on cholinesterases in mice.
Valuskova P; Farar V; Janisova K; Ondicova K; Mravec B; Kvetnansky R; Myslivecek J
Stress; 2017 Jan; 20(1):36-43. PubMed ID: 27873537
[TBL] [Abstract][Full Text] [Related]
32. Influence of differential expression of acetylcholinesterase in brain and muscle on respiration.
Boudinot E; Bernard V; Camp S; Taylor P; Champagnat J; Krejci E; Foutz AS
Respir Physiol Neurobiol; 2009 Jan; 165(1):40-8. PubMed ID: 18977317
[TBL] [Abstract][Full Text] [Related]
33. Schwann cells sense and control acetylcholine spillover at the neuromuscular junction by α7 nicotinic receptors and butyrylcholinesterase.
Petrov KA; Girard E; Nikitashina AD; Colasante C; Bernard V; Nurullin L; Leroy J; Samigullin D; Colak O; Nikolsky E; Plaud B; Krejci E
J Neurosci; 2014 Sep; 34(36):11870-83. PubMed ID: 25186736
[TBL] [Abstract][Full Text] [Related]
34. Resistance to organophosphorus agent toxicity in transgenic mice expressing the G117H mutant of human butyrylcholinesterase.
Wang Y; Boeck AT; Duysen EG; Van Keuren M; Saunders TL; Lockridge O
Toxicol Appl Pharmacol; 2004 May; 196(3):356-66. PubMed ID: 15094306
[TBL] [Abstract][Full Text] [Related]
35. The pH dependence of dealkylation in soman-inhibited cholinesterases and their mutants: further evidence for a push-pull mechanism.
Saxena A; Viragh C; Frazier DS; Kovach IM; Maxwell DM; Lockridge O; Doctor BP
Biochemistry; 1998 Oct; 37(43):15086-96. PubMed ID: 9790671
[TBL] [Abstract][Full Text] [Related]
36. Excessive hippocampal acetylcholine levels in acetylcholinesterase-deficient mice are moderated by butyrylcholinesterase activity.
Hartmann J; Kiewert C; Duysen EG; Lockridge O; Greig NH; Klein J
J Neurochem; 2007 Mar; 100(5):1421-9. PubMed ID: 17212694
[TBL] [Abstract][Full Text] [Related]
37. Acetylcholinesterase and butyrylcholinesterase activities in brain and plasma of freshwater teleosts: cross-species and cross-family differences.
Chuiko GM; Podgornaya VA; Zhelnin YY
Comp Biochem Physiol B Biochem Mol Biol; 2003 May; 135(1):55-61. PubMed ID: 12781973
[TBL] [Abstract][Full Text] [Related]
38. Potential of two new oximes in reactivate human acetylcholinesterase and butyrylcholinesterase inhibited by organophosphate compounds: an in vitro study.
Costa MD; Freitas ML; Soares FA; Carratu VS; Brandão R
Toxicol In Vitro; 2011 Dec; 25(8):2120-3. PubMed ID: 21983245
[TBL] [Abstract][Full Text] [Related]
39. Protection from the toxicity of diisopropylfluorophosphate by adeno-associated virus expressing acetylcholinesterase.
Li B; Duysen EG; Poluektova LY; Murrin LC; Lockridge O
Toxicol Appl Pharmacol; 2006 Jul; 214(2):152-65. PubMed ID: 16443250
[TBL] [Abstract][Full Text] [Related]
40. Caffeine inhibits acetylcholinesterase, but not butyrylcholinesterase.
Pohanka M; Dobes P
Int J Mol Sci; 2013 May; 14(5):9873-82. PubMed ID: 23698772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]